Immunogenicity and safety of concomitant and sequential administration of yellow fever YF-17D vaccine and tetravalent dengue vaccine candidate TAK-003: A phase 3 randomized, controlled study.
Vianney TricouBrandon EssinkJohn E ErvinMark TurnerIan EscuderoMartina RauscherManja BroseInge LefevreAstrid BorkowskiDerek WallacePublished in: PLoS neglected tropical diseases (2023)
ClinicalTrials.gov identified: NCT03342898.